Image

Study Reference No. 22-1058

Study Type Demographic Gender Age Location Compensation
Investigational Oral Medicated Study Healthy volunteers Males and Females 18 - 55 years old Saint Petersburg FL $1,375.00
Study Details

Study Objective

The purpose of this study is to see if an investigational [new/not available on the market and not yet approved by the U.S Food and Drug Administration (FDA)] capsule is bioequivalent (where the active test study drug is absorbed into the body at the same rate and amount as an already approved drug) to a currently marketed capsule, as well as to monitor the safety of the study participants.

Study Schedule

General Screening

N/A

Medical Screening

Thu, Apr 07, Tue, Apr 12 and Wed, Apr 13

Study Visit(s)

Group 1 / Period I
Check-in: Fri, Mar 04,2022
Check-out: Sun, Mar 06,2022
Ambulatory Visit 1: Sun, Mar 06,2022
Ambulatory Visit 2: Mon, Mar 07,2022


Group 1 / Period II
Check-in: Sun, Mar 13,2022
Check-out:Tue, Mar 15,2022
Ambulatory Visit 1: Tue, Mar 15,2022
Ambulatory Visit 2: Wed, Mar 16,2022


Group 2 / Period I - TBD


Group 2 / Period II - TBD

Follow-Up Visit(s)

N/A

Other Notes

General good health and non-smoker

Study requires overnight stays